Pluto Biosciences

Denver, United States Founded: 2020 • Age: 6 yrs
Cloud-based data management for scientific research is offered.

About Pluto Biosciences

Pluto Biosciences is a Healthcare company based in Denver (United States) founded in 2020 by Rani Powers. Cloud-based data management for scientific research is offered. Pluto Biosciences has raised $7.7 million across 3 funding rounds from investors including Silverton Partners. Its chief executive, as recorded, is Rani Powers. Its website pluto.bio draws about 15 thousand monthly visits. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Informatics. Its legal entity is Pluto Biosciences, Inc. Its competitors include Cellworks, Genuity Science and Codetta; 3 of its 3 listed competitors have raised funding.

Company details

Pluto Biosciences was founded in 2020 and is headquartered in Denver, United States. A cloud-based platform for laboratory data management is provided to scientists in the biotechnology sector. Experiment data is captured and organized, while features for data sharing, literature comparison, and bioinformatics analysis are included. Operations focus on streamlining research workflows through secure, accessible tools.

  • Headquarters Denver, United States
  • Founders Rani Powers
  • Sectors
    Healthcare
  • Website pluto.bio
  • Social LinkedIn X YouTube
  • Legal Name Pluto Biosciences, Inc.
Key Metrics
  • Total Equity Funding
    $7.7M (USD)

    in 3 rounds

  • Latest Funding Round
    $3M (USD), Seed

    Apr 2025

  • Investors

Apps and channels of Pluto Biosciences

its YouTube channel Pluto Bio has 68 subscribers and 26 videos.

Pluto Bio
YouTube 68 subscribers 26 videos Science & Technology
Open channel

Videos from Pluto Biosciences

The most watched videos on Pluto Biosciences's YouTube channel, Pluto Bio (68 subscribers). Click a video to play it here.

Analyzing RNA-seq data from raw counts in Pluto
2.2K views
Multi-Experiment Comparisons with Canvas Embedded Plots | Pluto Bio
1.9K views
Experimental data analysis canvas | Pluto Bio
1.3K views
Case study: Investigating SHH activation in medulloblastoma with differential expression | Pluto Bio
1K views

More on Pluto Bio.

Funding Insights of Pluto Biosciences

Pluto Biosciences has successfully raised a total of $7.7M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $3 million completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $7.7M
  • Total Rounds 3
  • Last Round Seed β€” $3M
  • First Round $1M

    (Oct 2021)

  • Investors Count 1

All 3 funding rounds of Pluto Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2025$3MSeed––
–
May 2023$3.7MSeed–Silverton Partners
–
Oct 2021$1MSeed––
–
Valuation history

1 investors in total: 1 institutional.

Investors in Pluto Biosciences

Pluto Biosciences has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Silverton Partners.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Tech companies are funded through venture capital by Silverton Partners.
silvertonpartners.comAustin, United States
Premium access

Investor details for Pluto Biosciences

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Pluto Biosciences

9 people are tracked at Pluto Biosciences (3 in leadership, 6 in team).

NameRoleGroup
Rani Powers
Founder & CEOLeadership
Jim Hanifen
Head of ProductLeadership
Jennifer Ullom
Head Of MarketingLeadership
Daniel Shin
Founding EngineerTeam
Steve Baker
GTM AdvisorTeam
Katie Blackman
DesignerTeam
Tiffany Tran
Software EngineerTeam
Nora Kearns
Bioinformatics Solutions EngineerTeam
Caitlin Winkler
Senior Solutions ScientistTeam
Premium access

Complete people profiles for Pluto Biosciences

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Pluto Biosciences

3 dated milestones of Pluto Biosciences across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Pluto Biosciences is founded.
  2. Funding First funding round of $1.0M.
  3. Funding Latest funding round, Seed, of $3.0M.

Competitors of Pluto Biosciences

Pluto Biosciences has 3 listed competitors in our database, 3 of them funded. They include Cellworks, Genuity Science and Codetta.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
cellworks.life2005San Jose, United States$16.52M
Biosimulation platform developed for therapeutic design in life sciences.
genuitysci.com2013Boston, United States$515M
AI-based omics data analysis solutions are provided to researchers.
codettabio.com2021Morrisville, United States$27.28M
Omics clinical data is analyzed through an online platform.
Premium access

Detailed competitors of Pluto Biosciences

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Pluto Biosciences

The website of Pluto Biosciences (pluto.bio) receives about 15.2K visits a month.

  • Monthly visits
    15.2K

    ▲ 27.4% vs previous month

Similar websites

Websites whose visitors overlap most with Pluto Biosciences. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
basepairtech.com
100%
13.3K#1,123,186View details
metwarebio.com
metwarebio.com
93%
#676,981–
bigomics.ch
88%
27.8K#1,116,345View details
chanzuckerberg.com
86%
85.7K#443,948View details
accurascience.com
83%
#7,335,263View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 16 similar websites and full traffic analytics for Pluto Biosciences

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 16 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Pluto Biosciences (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Pluto Biosciences

Premium access

Complete news archive for Pluto Biosciences

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pluto Biosciences

Pluto Biosciences was founded in 2020 and raised its 1st funding round 1 year after it was founded.

Pluto Biosciences is headquartered in Denver, United States. It is registered at Denver, Colorado, United States.

Rani Powers is the CEO of Pluto Biosciences, as recorded in our data. They have also founded this company.

Pluto Biosciences is a funded company, having raised a total of $7.7M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1M, raised on Oct 2021.

Pluto Biosciences was founded in 2020 and is headquartered in Denver, United States. A cloud-based platform for laboratory data management is provided to scientists in the biotechnology sector. Experiment data is captured and organized, while features for data sharing, literature comparison, and bioinformatics analysis are included. Operations focus on streamlining research workflows through secure, accessible tools.

Pluto Biosciences's top competitors include Cellworks, Codetta and Genuity Science.

Pluto Biosciences has 1 investor. Key investors include Silverton Partners.

Pluto Biosciences operates through Pluto Biosciences, Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available